Agile Therapeutics Inc (AGRX)
0.40
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:49
Agile Therapeutics Total Liabilities (Quarterly): 26.57M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.57M |
| September 30, 2023 | 23.30M |
| June 30, 2023 | 24.69M |
| March 31, 2023 | 23.13M |
| December 31, 2022 | 19.79M |
| September 30, 2022 | 12.20M |
| June 30, 2022 | 29.41M |
| March 31, 2022 | 26.56M |
| December 31, 2021 | 35.42M |
| September 30, 2021 | 26.00M |
| June 30, 2021 | 27.67M |
| March 31, 2021 | 24.42M |
| December 31, 2020 | 23.73M |
| September 30, 2020 | 23.28M |
| June 30, 2020 | 22.27M |
| March 31, 2020 | 18.28M |
| December 31, 2019 | 3.795M |
| September 30, 2019 | 1.929M |
| June 30, 2019 | 1.856M |
| March 31, 2019 | 1.468M |
| December 31, 2018 | 2.218M |
| Date | Value |
|---|---|
| September 30, 2018 | 8.415M |
| June 30, 2018 | 10.35M |
| March 31, 2018 | 12.31M |
| December 31, 2017 | 14.27M |
| September 30, 2017 | 16.85M |
| June 30, 2017 | 18.11M |
| March 31, 2017 | 21.01M |
| December 31, 2016 | 21.58M |
| September 30, 2016 | 20.44M |
| June 30, 2016 | 20.12M |
| March 31, 2016 | 19.88M |
| December 31, 2015 | 20.68M |
| September 30, 2015 | 22.34M |
| June 30, 2015 | 20.49M |
| March 31, 2015 | 19.94M |
| December 31, 2014 | 18.82M |
| September 30, 2014 | 18.48M |
| June 30, 2014 | 17.92M |
| March 31, 2014 | 86.29M |
| December 31, 2013 | 85.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.856M
Minimum
Jun 2019
35.42M
Maximum
Dec 2021
20.75M
Average
23.30M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Altimmune Inc | 16.54M |
| iBio Inc | 24.82M |
| Verastem Inc | 92.34M |
| Oragenics Inc | 1.798M |
| Actinium Pharmaceuticals Inc | 45.07M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.26M |
| Shareholders Equity (Quarterly) | -16.32M |
| Debt to Equity Ratio | -0.1045 |
| Current Ratio | 0.4587 |
| Net Debt Paydown Yield | -1.34% |